News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tekmira Pharmaceuticals Corporation (TKMR) Says Ebola Drug Not Used To Treat U.S. Aid Workers


8/4/2014 9:18:55 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Canada's Tekmira Pharmaceuticals Corp.,, whose shares have soared in the past fortnight on hopes for its Ebola therapy, said its drug was not used to treat two U.S. aid workers who were recently infected, a Canadian news agency reported.

Tekmira hopes to produce the first treatment for the deadly virus, which has killed more than 700 people in West Africa since February, and there had been speculation its therapy was given to American missionary Nancy Writebol and another aid worker, Dr. Kent Brantly.

Writebol and Brantly, who work for U.S.-based Christian relief groups SIM and Samaritan's Purse, were both infected in Liberia. Brantly is being treated at the Emory University Hospital in Atlanta.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES